| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $44.1M | +35.0% |
| Cost of Revenue | $10.1M | +24.7% |
| Gross Profit | $34.0M | +38.4% |
| R&D Expense | $1.4M | +101.0% |
| SG&A Expense | $19.4M | +70.7% |
| Operating Income | $4.9M | -8.7% |
| Interest Expense | $12.6M | +0.0% |
| Pre-tax Income | $11.9M | +136.0% |
| Income Tax | $86K | +218.5% |
| Net Income | $11.8M | +137.7% |
| EPS (Basic) | $1.38 | +119.6% |
| EPS (Diluted) | $0.41 | +105.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.0M | +16.8% |
| Accounts Receivable | $5.4M | +62.9% |
| Inventory | $5.9M | +43.0% |
| Current Assets | $24.6M | +33.9% |
| Total Assets | $37.3M | +24.0% |
| Current Liabilities | $17.8M | -57.9% |
| Long-term Debt | $21.9M | — |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.9M | +57.9% |
| Capital Expenditures | $1.9M | +296.3% |
| Investing Cash Flow | $3.4M | +800.6% |
| Financing Cash Flow | -$5.6M | -187.9% |
| Free Cash Flow | $1.9M | -1.6% |
| $35.7M |
| -16.6% |
| Stockholders' Equity | $1.6M | +112.7% |